TG Therapeutics: An Immunology Powerhouse | Latest News RSS feed

TG Therapeutics: An Immunology Powerhouse - Latest News

TG Therapeutics: An Immunology Powerhouse

Finances: Enough liquid assets to support the company until at least Q1 2019, with similar cash burns expected in the near future. Market potential by indication: $1.7 billion (relapsed/refractory CLL ... read more

Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology Antibodies

Checkpoint and TG Therapeutics ... Checkpoint Therapeutics, Inc., to develop a portfolio of fully human immuno-oncology targeted antibodies generated in the laboratory of Dr. Wayne Marasco, MD, PhD, a ... read more

Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development

December 27, 2007 09:59 ET | Source: TG Therapeutics ... aesthetic and medical, dermatologic therapeutics. Prior to Revance, she was Senior Director, Medical Research, Immunology at Biogen Idec, Inc. ... read more

Looking for another news?

Investors Should Exercise Caution With REVO Biologics IPO

Dr. Echelard currently serves as a director of TG Therapeutics (NASDAQ: TGTX) and as a director of GTC Biotherapeutics UK Limited. Dr. Echelard received a Ph.D. in microbiology and immunology from the ... read more

Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

Companies such as BioLineRx, Emergent BioSolutions, Infinity Pharmaceuticals, and TG Therapeutics are expected to enter ... and sells products across various therapy areas, including immunology, infec... read more

Flare-responsive hydrogel developed to treat arthritis

"Although new therapeutics have been developed ... The newly created flare-responsive hydrogel is made from triglycerol monostearate (TG-18), a compound from the Food and Drug Administration's list of ... read more

Gritstone Oncology : Appoints Dr. Karin Jooss as Chief Scientific Officer

where she worked up through the ranks of immunology science, building skills including comprehensive T cell characterization and robust, clinical-grade immune-assay development. "Our goal is to build ... read more

Confluence’s $100 million acquisition is a win for St. Louis’ biotech sector

Yesterday, BioGenerator’s first co-working lab tenant, Confluence Life Sciences, got acquired by Aclaris Therapeutics ... by the team of St. Louis scientists’ achievements in immunology, as a whole. A... read more

TG Therapeutics, Inc. to Present at the 2017 Jefferies Global Healthcare Conference

NEW YORK, June 06, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will present at the ... read more

Lungs in space: research project could lead to new lung therapeutics

UTMB and HMRI researchers say what they learn from the study could have real implications for astronauts, as well as those still on Earth, and could lead to future therapeutics ... Medicine and Microb... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us